Hearing on Food and Drug Administration Activities.

Continuation of hearings to review FDA regulatory policies. Examines regulation of oral contraceptives, particularly the new drug Demulen, FDA drug approval process and labeling regulations, and research on possible health risks of oral contraceptives containing high dosages of estrogen.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (other agent associated with work.)
Format:	eBook
Language:	English
Published:	[Washington : U.S. G.P.O.], 1970.
Subjects:	Contraceptives. Drugs. Estrogen.
Online Access:	Electronic resource (PDF)

Description
Summary:	Continuation of hearings to review FDA regulatory policies. Examines regulation of oral contraceptives, particularly the new drug Demulen, FDA drug approval process and labeling regulations, and research on possible health risks of oral contraceptives containing high dosages of estrogen.
Item Description:	Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection(last viewed July 2018). Reuse except for individual research requires license from ProQuest, LLC. Electronic resource.
Physical Description:	102 pages, digital, PDF file.
Format:	System requirements: PDF reader software.